Aventiv Research Appoints Roy St. John, M.D. as Medical Director, Principal Investigator

    COLUMBUS, OH, February 22, 2022 /24-7PressRelease/ -- Aventiv Research, a leading independent, multi-therapeutic inpatient and outpatient clinical research center, is pleased to announce the appointment of Roy St. John, M.D., Medical Director. As the medical director, Dr. St. John will serve as the physician responsible for guiding the overall medical care that is provided to patients and implementing best practices to conduct clinical research. He will also contribute to the development of new physician relationships to achieve and exceed patient enrollment goals. He brings with him 25 years of medical experience, was awarded the Lifeline of Ohio Physician of the Year Award in 2012, and has a rich background in clinical research.

"My immediate goals are to touch base with key leadership personnel who are responsible for quality and safety to gain an understanding of where we are, and to elicit ideas and suggestions to improve our core processes," said Dr. St. John. "I am also planning on meeting with principal investigators and sub-investigators to discuss current relevant topics, troubleshoot problems, and field questions and suggestions."

Under the guidance of Dr. St. John, his expertise and leadership will strengthen the breadth of care and quality of interactions patients experience with our medical and clinical staff. "Roy brings unparalleled attention to detail, and the ability to teach," offered Samir Arora, M.D., Founder and Chief Executive Officer of Aventiv. "He has received multiple teaching awards during his career, helping to educate medical students and residents, has been Principal Investigator on over 100 clinical trials, and I am confident in his ability to lead and mentor our team."

Dr. St. John believes the future of Aventiv is bright and exciting because of Dr. Arora's experience, leadership, and vision. "It has been a privilege to witness the growth of the company, and I am honored and blessed to be a part of the incredible team he has assembled," added Dr. St. John. "I am confident that Aventiv Research will rise to become one of the best and most successful clinical research companies in the U.S. in the next few years."

Dr. St. John attended medical school and completed his residency at the Ohio State University and is board-certified in pulmonology and critical care medicine.

For more information about Aventiv Research, visit https://www.aventivresearch.com/.

About Aventiv Research

Aventiv Research exists to make novel medicines accessible to its patients and deliver industry-best pharmaceutical data to its sponsors. Its mission is to enrich the lives of both its team members and patients by putting medical research to work. Currently operating in two states with seven independent research sites, Aventiv specializes in phase I-IV pharmaceutical, device, and diagnostic clinical trials in a variety of therapeutic areas. Built on the core values of dedication, integrity, resourcefulness, and professionalism, the company embraces a visionary, entrepreneurial spirit that compels its ambassadors to blaze new trails with proprietary systems and processes.

Founded in 2007 by Dr. Samir Arora, a proven leader with more than 15 years of clinical research experience, Aventiv Research has conducted over 475 clinical trials with more than 55 pharmaceutical sponsors and has helped 26 drugs to become approved by the FDA and available for use.

Find out more at www.aventivresearch.com, Facebook, and Instagram.

# # #